Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Lotus Private Placement Includes Make Good Clause

publication date: Feb 26, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Lotus Pharmaceuticals, Inc. raised $5 million by selling 5,747,118 series A convertible redeemable preferred shares in a private placement at a price of 80 cents per share. The offering contained an interesting “make good” clause. Lotus founders put 7.5 million of their personal shares into an escrow account, which will be released back to the founders if Lotus meets specified financial goals for 2007-2009 and if Lotus migrates to an NASDAQ listing. More details...

Stock Symbol: (OTCBB: LTUS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners